ENCORAFENIB vs ENOXAPARIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ENCORAFENIB vs ENOXAPARIN: Safety Overview
| Metric | ENCORAFENIB | ENOXAPARIN |
|---|---|---|
| Total FAERS Reports | 8,554 | 25,056 |
| Deaths Reported | 1,397 | 3,423 |
| Death Rate | 16.3% | 13.7% |
| Hospitalizations | 2,334 | 10,898 |
| Average Patient Age | 64.4 yrs | 60.3 yrs |
| % Female Patients | 50.9% | 55.9% |
| FDA Approval Date | Jun 27, 2018 | Jan 23, 2003 |
| Manufacturer | Array BioPharma Inc. | Italfarmaco SpA |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Discontinued | Prescription |